Evidence map›Paper›PMID 34868216›Full record

ArticleFrontiers in genetics2021

A Novel

Paschalis Nicolaou, George A Tanteles, Christina Votsi, Eleni Zamba-Papanicolaou, Savvas S Papacostas, Kyproula Christodoulou, Yiolanda-Panayiota Christou

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Neurology. Genetics · 2024
    Article
  3. Article
  4. Rare adult neuronal ceroid lipofuscinosis associated withWorld journal of clinical cases · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Paschalis NicolaouDepartment of Neurogenetics, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
George A TantelesDepartment of Clinical Genetics and Genomics, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Christina VotsiDepartment of Neurogenetics, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Eleni Zamba-PapanicolaouDepartment of Neuroepidemiology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Savvas S PapacostasDepartment of Neurobiology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Kyproula ChristodoulouDepartment of Neurogenetics, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Yiolanda-Panayiota ChristouDepartment of Neurobiology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Cyprus Institute of Neurology and Genetics · CY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neuronal ceroid lipofuscinoses (NCLs), also known as Batten disease, are a group of autosomal recessive lysosomal storage disorders that are characterized by neurodegeneration, progressive cognitive decline, motor impairment, ataxia, loss of vision, seizures, and premature death. To date, pathogenic variants in more than 13 genes have been associated with NCLs.

Indexed as

batten diseaseCNL6in silico predictionlysosomal storage disordersneuronal ceroid lipofuscinosisnext-generation sequencing

Identifiers

PMID34868216
PMCPMC8640139
OpenAlexW3214517797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.